Structure of the carbohydrate moiety of human interferon-beta secreted by a recombinant Chinese hamster ovary cell line
- PMID: 3667593
Structure of the carbohydrate moiety of human interferon-beta secreted by a recombinant Chinese hamster ovary cell line
Abstract
The carbohydrate structure of the major oligosaccharide of human interferon-beta (IFN-beta) synthesized by a genetically engineered Chinese hamster ovary cell line has been determined. Analysis of the glycopeptidase F-released carbohydrates by sequential exoglycosidase treatment, methylation analysis, and fast atom bombardment-mass spectrometry revealed that 95% of the IFN-beta oligosaccharides had the following structure: (Formula: see text). The remaining 5% of the carbohydrates are probably tri- or higher antennary oligosaccharide chains. The major oligosaccharide of the recombinant IFN-beta is remarkably homogeneous with respect to terminal galactose sialylation. NeuAc, which is alpha 2-3-linked to galactose in the human IFN-beta secreted by Chinese hamster ovary cells, can be re-incorporated with an alpha 2-6 linkage in vitro, into enzymatically desialylated IFN-beta using rat liver Gal beta 1-4GlcNAc alpha 2-6 sialyltransferase. The sugar chain is important for maintaining protein solubility as shown by the fact that IFN-beta protein precipitates after deglycosylation with glycopeptidase F.
Similar articles
-
Structure determination of the intact major sialylated oligosaccharide chains of recombinant human erythropoietin expressed in Chinese hamster ovary cells.Glycobiology. 1994 Apr;4(2):227-37. doi: 10.1093/glycob/4.2.227. Glycobiology. 1994. PMID: 8054720
-
Structural characterization by chromatographic profiling of the oligosaccharides of human immunodeficiency virus (HIV) recombinant envelope glycoprotein gp120 produced in Chinese hamster ovary cells.Biomed Chromatogr. 1988 Nov;2(6):260-70. doi: 10.1002/bmc.1130020608. Biomed Chromatogr. 1988. PMID: 2852980
-
Construction of stable BHK-21 cells coexpressing human secretory glycoproteins and human Gal(beta 1-4)GlcNAc-R alpha 2,6-sialyltransferase alpha 2,6-linked NeuAc is preferentially attached to the Gal(beta 1-4)GlcNAc(beta 1-2)Man(alpha 1-3)-branch of diantennary oligosaccharides from secreted recombinant beta-trace protein.Eur J Biochem. 1995 Sep 15;232(3):718-25. doi: 10.1111/j.1432-1033.1995.718zz.x. Eur J Biochem. 1995. PMID: 7588709
-
Carbohydrate structures of human tissue plasminogen activator expressed in Chinese hamster ovary cells.J Biol Chem. 1989 Aug 25;264(24):14100-11. J Biol Chem. 1989. PMID: 2503511
-
The glycosylation heterogeneity of recombinant human IFN-gamma.J Interferon Cytokine Res. 1998 May;18(5):287-95. doi: 10.1089/jir.1998.18.287. J Interferon Cytokine Res. 1998. PMID: 9620355 Review.
Cited by
-
Identification of oxidation sites and covalent cross-links in metal catalyzed oxidized interferon Beta-1a: potential implications for protein aggregation and immunogenicity.Mol Pharm. 2013 Jun 3;10(6):2311-22. doi: 10.1021/mp300665u. Epub 2013 May 2. Mol Pharm. 2013. PMID: 23534382 Free PMC article.
-
Appropriate glycosylation of recombinant proteins for human use: implications of choice of expression system.Mol Biotechnol. 2004 Nov;28(3):241-55. doi: 10.1385/MB:28:3:241. Mol Biotechnol. 2004. PMID: 15542924 Review.
-
Structural and functional differences between glycosylated and non-glycosylated forms of human interferon-beta (IFN-beta).Pharm Res. 1998 Apr;15(4):641-9. doi: 10.1023/a:1011974512425. Pharm Res. 1998. PMID: 9587963
-
Effects of glycosylation on the stability of protein pharmaceuticals.J Pharm Sci. 2009 Apr;98(4):1223-45. doi: 10.1002/jps.21504. J Pharm Sci. 2009. PMID: 18661536 Free PMC article. Review.
-
Glycosylation of therapeutic proteins: an effective strategy to optimize efficacy.BioDrugs. 2010 Feb 1;24(1):9-21. doi: 10.2165/11530550-000000000-00000. BioDrugs. 2010. PMID: 20055529 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases